Risk factors for the development of clostridium difficile infection in hospitalized children

Current Opinion in Pediatrics

Volumn 26, Issue 5, 2014, Pages 568-572

  Samady, Waheeda ^a,b   Pong, Alice ^c   Fisherd, Erin ^c  

^a NORTHWESTERN UNIVERSITY   (United States)

^b CHILDREN'S MEMORIAL HOSPITAL   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Clostridium difficile infection; Hospital acquired; Hospitalized pediatric patients; Risk factors

Indexed keywords

ANTIBIOTIC AGENT; ANTIINFECTIVE AGENT;

AGE; CLOSTRIDIUM DIFFICILE INFECTION; COLON RESECTION; DISEASE MARKER; DISEASE SEVERITY; EXPOSURE; HOSPITAL INFECTION; HOSPITAL PATIENT; HOSPITALIZATION; HUMAN; IMMUNE DEFICIENCY; INFLAMMATORY BOWEL DISEASE; NEOPLASM; PRIORITY JOURNAL; REVIEW; RISK FACTOR; STOMACH ACID SECRETION; AGE DISTRIBUTION; CHILD; CLOSTRIDIUM INFECTIONS; COMORBIDITY; CROSS INFECTION; HOSPITALIZED CHILD; IMMUNOLOGY; INCIDENCE; INFANT; INFLAMMATORY BOWEL DISEASES; ISOLATION AND PURIFICATION; NEOPLASMS; NEWBORN; PEPTOCLOSTRIDIUM DIFFICILE; PRESCHOOL CHILD; STATISTICS AND NUMERICAL DATA;

AGE DISTRIBUTION; ANTI-BACTERIAL AGENTS; CHILD; CHILD, HOSPITALIZED; CHILD, PRESCHOOL; CLOSTRIDIUM DIFFICILE; CLOSTRIDIUM INFECTIONS; COMORBIDITY; CROSS INFECTION; HUMANS; INCIDENCE; INFANT; INFANT, NEWBORN; INFLAMMATORY BOWEL DISEASES; NEOPLASMS; RISK FACTORS;

EID: 84928208666     PISSN: 10408703     EISSN: 1531698X     Source Type: Journal    
DOI: 10.1097/MOP.0000000000000126     Document Type: Review

References (50)

1. Dubberke ER, Gerding DN, Classen D, et al. Strategies to prevent clostridium difficile infections in acute care hospitals. Infect Control Hosp Epidemiol 2008; 29(1 Suppl 1):S81-S92.
2. Langley JM, LeBlanc JC, Hanakowski M, Goloubeva O. The role of Clostridium difficile and viruses as causes of nosocomial diarrhea in children. Infect Control Hosp Epidemiol 2002; 23:660-664.
3. Magill SS, Edwards JR, Bamberg W, et al. Multistate point-prevalence survey of health care-associated infections. N Engl J Med 2014; 370:1198-1208.
4. McDonald LC, Killgore GE, Thompson A, et al. An epidemic, toxin genevariant strain of Clostridium difficile. N Engl J Med 2005; 353:2433-2441.
5. Warny M, Pepin J, Fang A, et al. Toxin production by an emerging strain of Clostridium difficile associated with outbreaks of severe disease in North America and Europe. Lancet 2005; 366:1079-1084.
6. Duleba K, Pawlowska M, Wietlicka-Piszcz M. Clostridium difficile infection in children hospitalized due to diarrhea. Eur J Clin Microbiol Infect Dis 2014; 33:201-209.
7. Kim J, Shaklee JF, Smathers S, et al. Risk factors and outcomes associated with severe clostridium difficile infection in children. Pediatr Infect Dis J 2012; 31:134-138.
8. Schwartz KL, Darwish I, Richardson SE, et al. Severe clinical outcome is uncommon in Clostridium difficile infection in children: A retrospective cohort study. BMC Pediatr 2014; 14:28.
9. Toltzis P, Kim J, Dul M, et al. Presence of the epidemic North American Pulsed Field type 1 Clostridium difficile strain in hospitalized children. J Pediatr 2009; 154:607-608.
10. Kim J, Smathers SA, Prasad P, et al. Epidemiological features of Clostridium difficile-associated disease among inpatients at children's hospitals in the United States, 2001-2006. Pediatrics 2008; 122:1266-1270.
11. Nylund CM, Goudie A, Garza JM, et al. Clostridium difficile infection in hospitalized children in the United States. Arch Pediatr Adolesc Med 2011; 165:451-457.
12. Benson L, Song X, Campos J, Singh N. Changing epidemiology of Clostridium difficile-associated disease in children. Infect Control Hosp Epidemiol 2007; 28:1233-1235.
13. Deshpande A, Pant C, Anderson MP, et al. Clostridium difficile infection in the hospitalized pediatric population: increasing trend in disease incidence. Pediatr Infect Dis J 2013; 32:1138-1140.
14. Khanna S, Baddour LM, Huskins WC, et al. The epidemiology of Clostridium difficile infection in children: A population-based study. Clin Infect Dis 2013; 56:1401-1406.
15. Zilberberg MD, Tillotson GS, McDonald C. Clostridium difficile infections among hospitalized children, United States, 1997-2006. Emerg Infect Dis 2010; 16:604-609.
16. Zilberberg MD, Shorr AF, Kollef MH. Increase in Clostridium difficilerelated hospitalizations among infants in the United States, 2000-2005. Pediatr Infect Dis J 2008; 27:1111-1113.
17. Centers for Disease Control and Prevention. Severe Clostridium difficileassociated disease in populations previously at low risk-four states, 2005. Morb Mortal Wkly Rep 2005; 54:1201-1205.
18. Bryant K, McDonald LC. Clostridium difficile infections in children. Pediatr Infect Dis J 2009; 28:145-146.
19. Sandora TJ, Fung M, Flaherty K, et al. Epidemiology and risk factors for Clostridium difficile infection in children. Pediatr Infect Dis J 2011; 30:580-584.
20. Samady W, Bush R, Pong A, et al. Predictors of Clostridium difficile infections in hospitalized children. J Hosp Med 2014; 9:94-98.
21. Jangi S, Lamont JT. Asymptomatic colonization by Clostridium difficile in infants: implications for disease in later life. J Pediatr Gastroenterol Nutr 2010; 51:2-7.
22. Pothoulakis C, Lamont JT. Microbes and microbial toxins: paradigms for microbial-mucosal interactions II. The integrated response of the intestine to Clostridium difficile toxins. Am J Physiol Gastrointest Liver Physiol 2001; 280:G178-G183.
23. Schutze GE, Willoughby RE; Committee on Infectious Diseases; American Academy of Pediatrics. Clostridium difficile infection in infants and children. Pediatrics 2013; 131:196-200.
24. Owens RC, Donskey CJ, Gaynes RP, et al. Antimicrobial-associated risk factors for Clostridium difficile infection. Clin Infect Dis 2008; 46(Suppl 1):S19-S31.
25. Morinville V, McDonald J. Clostridium difficile-associated diarrhea in 200 Canadian children. Can J Gastroenterol 2005; 19:497-501.
26. Cohen SH, Gerding DN, Johnson S, et al. Clinical practice guidelines for Clostridium difficile infection in adults: update by the society for healthcare epidemiology of America (SHEA) and the infectious diseases society of America (IDSA). Infect Control Hosp Epidemiol 2010; 31:431-455.
27. McDonald LC, Coignard B, Dubberke E, et al. Recommendations for surveillance of Clostridium difficile-associated disease. Infect Control Hosp Epidemiol 2007; 28:140-145.
28. Com G, Cetin N, O'Brien CE. Complicated Clostridium difficile colitis in children with cystic fibrosis: Association with gastric acid suppression? J Cyst Fibros 2014; 13:37-42.
29. De-Blank P, Zaoutis T, Fisher B, et al. Trends in Clostridium difficile infection and risk factors for hospital acquisition of Clostridium difficile among children with cancer. J Pediatr 2013; 163:699-705.
30. Price V, Portwine C, Zelcer S, et al. Clostridium difficile infection in pediatric acute myeloid leukemia: from the Canadian Infections in Acute Myeloid Leukemia Research Group. Pediatr Infect Dis J 2013; 32:610-613.
31. Rodemann JF, Dubberke ER, Reske KA, et al. Incidence of Clostridium difficile infection in inflammatory bowel disease. Clin Gastroenterol Hepatol 2007; 5:339-344.
32. Clayton EM, Rea MC, Shanahan F, et al. The vexed relationship between Clostridium difficile and inflammatory bowel disease: An assessment of carriage in an outpatient setting among patients in remission. Am J Gastroenterol 2009; 104:1162-1169.
33. Ananthakrishnan AN, McGinley EL, Saeian K, Binion DG. Temporal trends in disease outcomes related to Clostridium difficile infection in patients with inflammatory bowel disease. Inflamm Bowel Dis 2011; 17:976-983.
34. Ananthakrishnan AN, McGinley EL, Binion DG. Excess hospitalisation burden associated with Clostridium difficile in patients with inflammatory bowel disease. Gut 2008; 57:205-210.
35. Mezoff E, Mann EA, Hart KW, et al. Clostridium difficile infection and treatment in the pediatric inflammatory bowel disease population. J Pediatr Gastroenterol Nutr 2011; 52:437-441.
36. Pascarella F, Martinelli M, Miele E, et al. Impact of Clostridium difficile infection on pediatric inflammatory bowel disease. J Pediatr 2009; 154:854-858.
37. Banaszkiewicz A, Kowalska-Duplaga K, Pytrus T, et al. Clostridium difficile infection in newly diagnosed pediatric patients with inflammatory bowel disease: prevalence and risk factors. Inflamm Bowel Dis 2012; 18:844-848.
38. Ananthakrishnan AN, Issa M, Binion DG. Clostridium difficile and inflammatory bowel disease. Gastroenterol Clin North Am 2009; 38:711-728.
39. Sinh P, Barrett TA, Yun L. Clostridium difficile infection and inflammatory bowel disease: A review. Gastroenterol Res Pract 2011; 2011:136064.
40. Hourigan SK, Chirumamilla SR, Ross T, et al. Clostridium difficile carriage and serum antitoxin responses in children with inflammatory bowel disease. Inflamm Bowel Dis 2013; 19:2744-2752.
41. Jump RL, Pultz MJ, Donskey CJ. Vegetative Clostridium difficile survives in room air on moist surfaces and in gastric contents with reduced acidity: A potential mechanism to explain the association between proton pump inhibitors and C. difficile-associated diarrhea? Antimicrob Agents Chemother 2007; 51:2883-2887.
42. Barron JJ, Tan H, Spalding J, et al. Proton pump inhibitor utilization patterns in infants. J Pediatr Gastroenterol Nutr 2007; 45:421-427.
43. Tolia V, Boyer K. Long-term proton pump inhibitor use in children: A retrospective review of safety. Dig Dis Sci 2008; 53:385-393.
44. Yearsley KA, Gilby LJ, Ramadas AV, et al. Proton pump inhibitor therapy is a risk factor for Clostridium difficile-associated diarrhoea. Aliment Pharmacol Ther 2006; 24:613-619.
45. Dial S, Alrasadi K, Manoukian C, et al. Risk of Clostridium difficile diarrhea among hospital inpatients prescribed proton pump inhibitors: cohort and case-control studies. Can Med Assoc J 2004; 171:33-38.
46. Dial S, Delaney JA, Barkun AN, Suissa S. Use of gastric acid-suppressive agents and the risk of community-acquired Clostridium difficile-associated disease. JAMA 2005; 294:2989-2995.
47. Cunningham R, Dale B, Undy B, Gaunt N. Proton pump inhibitors as a risk factor for Clostridium difficile diarrhoea. J Hosp Infect 2003; 54:243-245.
48. Turco R, Martinelli M, Miele E, et al. Proton pump inhibitors as a risk factor for paediatric Clostridium difficile infection. Aliment Pharmacol Ther 2010; 31:754-759.
49. Sammons JS, Toltzis P, Zaoutis TE. Clostridium difficile Infection in children. JAMA Pediatr 2013; 167:567-573.
50. Zar FA, Bakkanagari SR, Moorthi KM, Davis MB. A comparison of vancomycin and metronidazole for the treatment of Clostridium difficileassociated diarrhea, stratified by disease severity. Clin Infect Dis 2007; 45:302-307.